Loading…

Efficient synthesis of new antiproliferative steroidal hybrids using the molecular hybridization approach

A series of steroidal hybrids with different terminal bioactive scaffolds were synthesized using the molecular hybridization approach and further evaluated for their antiproliferative activity against several cancer cell lines of different origins using the MTT assay. The preliminary results indicat...

Full description

Saved in:
Bibliographic Details
Published in:European journal of medicinal chemistry 2016-07, Vol.117, p.241-255
Main Authors: Yu, Bin, Qi, Ping-Ping, Shi, Xiao-Jing, Huang, Ruilei, Guo, Hao, Zheng, Yi-Chao, Yu, De-Quan, Liu, Hong-Min
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c362t-8314d13087206cbe3b2f84641d5080c5eb397fe7013432c9cd3cfc1bf47e203d3
cites cdi_FETCH-LOGICAL-c362t-8314d13087206cbe3b2f84641d5080c5eb397fe7013432c9cd3cfc1bf47e203d3
container_end_page 255
container_issue
container_start_page 241
container_title European journal of medicinal chemistry
container_volume 117
creator Yu, Bin
Qi, Ping-Ping
Shi, Xiao-Jing
Huang, Ruilei
Guo, Hao
Zheng, Yi-Chao
Yu, De-Quan
Liu, Hong-Min
description A series of steroidal hybrids with different terminal bioactive scaffolds were synthesized using the molecular hybridization approach and further evaluated for their antiproliferative activity against several cancer cell lines of different origins using the MTT assay. The preliminary results indicated that compounds 12a–h with the terminal isatin motif were remarkably sensitive to SH-SY5Y cells, thereby exerting potent growth inhibition in vitro. This selectivity is possibly attributed to LSD1 inactivation (IC50 = 3.18 μM). Besides, we also found that the chloro atom at the 7-position on the isatin core was beneficial for the activity through the SARs studies. Among this series, compound 12g showed the best inhibitory activity (IC50 = 4.06 μM) against SH-SY5Y cells, which was comparable to that of 5-FU. Compound 12g arrested cell cycle at G2/M phase, induced apoptosis accompanied with decrease of mitochondrial membrane potential, and inhibited LSD1 potently (IC50 = 3.18 μM). Docking studies showed that compound 12g formed interactions with surrounding amino acid residues and the steroid nucleus occupied the tubular hydrophobic cavity of the active site. Compounds 13–18 represented weak to moderate activity against the tested cancer cell lines. The steroidal dimer 20 and the structurally simplified non-steroidal dimer 21 were found to be devoid of the inhibitory activity. Steroidal hybrids were synthesized and evaluated for their antiproliferative activity. Compound 12g potently inhibited growth of SH-SY5Y cells possibly through the inactivation of LSD1, arrested cell cycle at G2/M phase, induced apoptosis and decreased MMP. Docking simulations were performed to rationalize the potency toward LSD1. [Display omitted] •Steroidal hybrids 12a–x were synthesized and showed varied cytotoxicity against the tested cancer cell lines.•Compounds with terminal isatin scaffold were sensitive to SH-SY5Y cells possibly through LSD1 inactivation.•Compound 12g potently inhibited growth of SH-SY5Y cells (IC50 = 4.06 μM).•Compound 12g arrested cell cycle at G2/M phase, induced apoptosis and decreased MMP.•Docking simulations were performed to show the binding models of compound 12g in the active site of LSD1.
doi_str_mv 10.1016/j.ejmech.2016.04.024
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1789498261</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0223523416303099</els_id><sourcerecordid>1789498261</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-8314d13087206cbe3b2f84641d5080c5eb397fe7013432c9cd3cfc1bf47e203d3</originalsourceid><addsrcrecordid>eNp9kMlKBDEQhoMoOi5vIJKjl24rSy9zEUTcQPCi55BOKk6GXsakWxmf3gwzevRUFPUv1EfIOYOcASuvljkuOzSLnKctB5kDl3tkxqqyzgQv5D6ZAeciK7iQR-Q4xiUAFCXAITniFYMCeD0j_s45bzz2I43rflxg9JEOjvb4RXU_-lUYWu8w6NF_Io0jhsFb3dLFugneRjpF37_T5KPd0KKZWh12N_-dPENP9SplaLM4JQdOtxHPdvOEvN3fvd4-Zs8vD0-3N8-ZESUfs1owaZmAuuJQmgZFw10tS8lsATWYAhsxrxxWwIQU3MyNFcYZ1jhZIQdhxQm53Oam2o8J46g6Hw22re5xmKJiVT2X85qXLEnlVmrCEGNAp1bBdzqsFQO1gayWagtZbSArkCpBTraLXcPUdGj_TL9Uk-B6K8D056fHoOIGsUHrA5pR2cH_3_ADf_WRZA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1789498261</pqid></control><display><type>article</type><title>Efficient synthesis of new antiproliferative steroidal hybrids using the molecular hybridization approach</title><source>ScienceDirect Freedom Collection</source><creator>Yu, Bin ; Qi, Ping-Ping ; Shi, Xiao-Jing ; Huang, Ruilei ; Guo, Hao ; Zheng, Yi-Chao ; Yu, De-Quan ; Liu, Hong-Min</creator><creatorcontrib>Yu, Bin ; Qi, Ping-Ping ; Shi, Xiao-Jing ; Huang, Ruilei ; Guo, Hao ; Zheng, Yi-Chao ; Yu, De-Quan ; Liu, Hong-Min</creatorcontrib><description>A series of steroidal hybrids with different terminal bioactive scaffolds were synthesized using the molecular hybridization approach and further evaluated for their antiproliferative activity against several cancer cell lines of different origins using the MTT assay. The preliminary results indicated that compounds 12a–h with the terminal isatin motif were remarkably sensitive to SH-SY5Y cells, thereby exerting potent growth inhibition in vitro. This selectivity is possibly attributed to LSD1 inactivation (IC50 = 3.18 μM). Besides, we also found that the chloro atom at the 7-position on the isatin core was beneficial for the activity through the SARs studies. Among this series, compound 12g showed the best inhibitory activity (IC50 = 4.06 μM) against SH-SY5Y cells, which was comparable to that of 5-FU. Compound 12g arrested cell cycle at G2/M phase, induced apoptosis accompanied with decrease of mitochondrial membrane potential, and inhibited LSD1 potently (IC50 = 3.18 μM). Docking studies showed that compound 12g formed interactions with surrounding amino acid residues and the steroid nucleus occupied the tubular hydrophobic cavity of the active site. Compounds 13–18 represented weak to moderate activity against the tested cancer cell lines. The steroidal dimer 20 and the structurally simplified non-steroidal dimer 21 were found to be devoid of the inhibitory activity. Steroidal hybrids were synthesized and evaluated for their antiproliferative activity. Compound 12g potently inhibited growth of SH-SY5Y cells possibly through the inactivation of LSD1, arrested cell cycle at G2/M phase, induced apoptosis and decreased MMP. Docking simulations were performed to rationalize the potency toward LSD1. [Display omitted] •Steroidal hybrids 12a–x were synthesized and showed varied cytotoxicity against the tested cancer cell lines.•Compounds with terminal isatin scaffold were sensitive to SH-SY5Y cells possibly through LSD1 inactivation.•Compound 12g potently inhibited growth of SH-SY5Y cells (IC50 = 4.06 μM).•Compound 12g arrested cell cycle at G2/M phase, induced apoptosis and decreased MMP.•Docking simulations were performed to show the binding models of compound 12g in the active site of LSD1.</description><identifier>ISSN: 0223-5234</identifier><identifier>EISSN: 1768-3254</identifier><identifier>DOI: 10.1016/j.ejmech.2016.04.024</identifier><identifier>PMID: 27105028</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Antiproliferative activity ; Apoptosis ; Catalytic Domain ; Cell cycle arrest ; Cell Line, Tumor ; Docking simulations ; Drug Screening Assays, Antitumor ; Humans ; Inhibitory Concentration 50 ; Isatin - chemistry ; Isatin - pharmacology ; LSD1 inactivation ; Molecular Docking Simulation ; Molecular hybridization ; Steroids ; Steroids - chemical synthesis ; Steroids - pharmacology ; Structure-Activity Relationship</subject><ispartof>European journal of medicinal chemistry, 2016-07, Vol.117, p.241-255</ispartof><rights>2016 Elsevier Masson SAS</rights><rights>Copyright © 2016 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-8314d13087206cbe3b2f84641d5080c5eb397fe7013432c9cd3cfc1bf47e203d3</citedby><cites>FETCH-LOGICAL-c362t-8314d13087206cbe3b2f84641d5080c5eb397fe7013432c9cd3cfc1bf47e203d3</cites><orcidid>0000-0002-5856-4568 ; 0000-0002-7143-9104</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27105028$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yu, Bin</creatorcontrib><creatorcontrib>Qi, Ping-Ping</creatorcontrib><creatorcontrib>Shi, Xiao-Jing</creatorcontrib><creatorcontrib>Huang, Ruilei</creatorcontrib><creatorcontrib>Guo, Hao</creatorcontrib><creatorcontrib>Zheng, Yi-Chao</creatorcontrib><creatorcontrib>Yu, De-Quan</creatorcontrib><creatorcontrib>Liu, Hong-Min</creatorcontrib><title>Efficient synthesis of new antiproliferative steroidal hybrids using the molecular hybridization approach</title><title>European journal of medicinal chemistry</title><addtitle>Eur J Med Chem</addtitle><description>A series of steroidal hybrids with different terminal bioactive scaffolds were synthesized using the molecular hybridization approach and further evaluated for their antiproliferative activity against several cancer cell lines of different origins using the MTT assay. The preliminary results indicated that compounds 12a–h with the terminal isatin motif were remarkably sensitive to SH-SY5Y cells, thereby exerting potent growth inhibition in vitro. This selectivity is possibly attributed to LSD1 inactivation (IC50 = 3.18 μM). Besides, we also found that the chloro atom at the 7-position on the isatin core was beneficial for the activity through the SARs studies. Among this series, compound 12g showed the best inhibitory activity (IC50 = 4.06 μM) against SH-SY5Y cells, which was comparable to that of 5-FU. Compound 12g arrested cell cycle at G2/M phase, induced apoptosis accompanied with decrease of mitochondrial membrane potential, and inhibited LSD1 potently (IC50 = 3.18 μM). Docking studies showed that compound 12g formed interactions with surrounding amino acid residues and the steroid nucleus occupied the tubular hydrophobic cavity of the active site. Compounds 13–18 represented weak to moderate activity against the tested cancer cell lines. The steroidal dimer 20 and the structurally simplified non-steroidal dimer 21 were found to be devoid of the inhibitory activity. Steroidal hybrids were synthesized and evaluated for their antiproliferative activity. Compound 12g potently inhibited growth of SH-SY5Y cells possibly through the inactivation of LSD1, arrested cell cycle at G2/M phase, induced apoptosis and decreased MMP. Docking simulations were performed to rationalize the potency toward LSD1. [Display omitted] •Steroidal hybrids 12a–x were synthesized and showed varied cytotoxicity against the tested cancer cell lines.•Compounds with terminal isatin scaffold were sensitive to SH-SY5Y cells possibly through LSD1 inactivation.•Compound 12g potently inhibited growth of SH-SY5Y cells (IC50 = 4.06 μM).•Compound 12g arrested cell cycle at G2/M phase, induced apoptosis and decreased MMP.•Docking simulations were performed to show the binding models of compound 12g in the active site of LSD1.</description><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Antiproliferative activity</subject><subject>Apoptosis</subject><subject>Catalytic Domain</subject><subject>Cell cycle arrest</subject><subject>Cell Line, Tumor</subject><subject>Docking simulations</subject><subject>Drug Screening Assays, Antitumor</subject><subject>Humans</subject><subject>Inhibitory Concentration 50</subject><subject>Isatin - chemistry</subject><subject>Isatin - pharmacology</subject><subject>LSD1 inactivation</subject><subject>Molecular Docking Simulation</subject><subject>Molecular hybridization</subject><subject>Steroids</subject><subject>Steroids - chemical synthesis</subject><subject>Steroids - pharmacology</subject><subject>Structure-Activity Relationship</subject><issn>0223-5234</issn><issn>1768-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9kMlKBDEQhoMoOi5vIJKjl24rSy9zEUTcQPCi55BOKk6GXsakWxmf3gwzevRUFPUv1EfIOYOcASuvljkuOzSLnKctB5kDl3tkxqqyzgQv5D6ZAeciK7iQR-Q4xiUAFCXAITniFYMCeD0j_s45bzz2I43rflxg9JEOjvb4RXU_-lUYWu8w6NF_Io0jhsFb3dLFugneRjpF37_T5KPd0KKZWh12N_-dPENP9SplaLM4JQdOtxHPdvOEvN3fvd4-Zs8vD0-3N8-ZESUfs1owaZmAuuJQmgZFw10tS8lsATWYAhsxrxxWwIQU3MyNFcYZ1jhZIQdhxQm53Oam2o8J46g6Hw22re5xmKJiVT2X85qXLEnlVmrCEGNAp1bBdzqsFQO1gayWagtZbSArkCpBTraLXcPUdGj_TL9Uk-B6K8D056fHoOIGsUHrA5pR2cH_3_ADf_WRZA</recordid><startdate>20160719</startdate><enddate>20160719</enddate><creator>Yu, Bin</creator><creator>Qi, Ping-Ping</creator><creator>Shi, Xiao-Jing</creator><creator>Huang, Ruilei</creator><creator>Guo, Hao</creator><creator>Zheng, Yi-Chao</creator><creator>Yu, De-Quan</creator><creator>Liu, Hong-Min</creator><general>Elsevier Masson SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5856-4568</orcidid><orcidid>https://orcid.org/0000-0002-7143-9104</orcidid></search><sort><creationdate>20160719</creationdate><title>Efficient synthesis of new antiproliferative steroidal hybrids using the molecular hybridization approach</title><author>Yu, Bin ; Qi, Ping-Ping ; Shi, Xiao-Jing ; Huang, Ruilei ; Guo, Hao ; Zheng, Yi-Chao ; Yu, De-Quan ; Liu, Hong-Min</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-8314d13087206cbe3b2f84641d5080c5eb397fe7013432c9cd3cfc1bf47e203d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Antiproliferative activity</topic><topic>Apoptosis</topic><topic>Catalytic Domain</topic><topic>Cell cycle arrest</topic><topic>Cell Line, Tumor</topic><topic>Docking simulations</topic><topic>Drug Screening Assays, Antitumor</topic><topic>Humans</topic><topic>Inhibitory Concentration 50</topic><topic>Isatin - chemistry</topic><topic>Isatin - pharmacology</topic><topic>LSD1 inactivation</topic><topic>Molecular Docking Simulation</topic><topic>Molecular hybridization</topic><topic>Steroids</topic><topic>Steroids - chemical synthesis</topic><topic>Steroids - pharmacology</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yu, Bin</creatorcontrib><creatorcontrib>Qi, Ping-Ping</creatorcontrib><creatorcontrib>Shi, Xiao-Jing</creatorcontrib><creatorcontrib>Huang, Ruilei</creatorcontrib><creatorcontrib>Guo, Hao</creatorcontrib><creatorcontrib>Zheng, Yi-Chao</creatorcontrib><creatorcontrib>Yu, De-Quan</creatorcontrib><creatorcontrib>Liu, Hong-Min</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yu, Bin</au><au>Qi, Ping-Ping</au><au>Shi, Xiao-Jing</au><au>Huang, Ruilei</au><au>Guo, Hao</au><au>Zheng, Yi-Chao</au><au>Yu, De-Quan</au><au>Liu, Hong-Min</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficient synthesis of new antiproliferative steroidal hybrids using the molecular hybridization approach</atitle><jtitle>European journal of medicinal chemistry</jtitle><addtitle>Eur J Med Chem</addtitle><date>2016-07-19</date><risdate>2016</risdate><volume>117</volume><spage>241</spage><epage>255</epage><pages>241-255</pages><issn>0223-5234</issn><eissn>1768-3254</eissn><abstract>A series of steroidal hybrids with different terminal bioactive scaffolds were synthesized using the molecular hybridization approach and further evaluated for their antiproliferative activity against several cancer cell lines of different origins using the MTT assay. The preliminary results indicated that compounds 12a–h with the terminal isatin motif were remarkably sensitive to SH-SY5Y cells, thereby exerting potent growth inhibition in vitro. This selectivity is possibly attributed to LSD1 inactivation (IC50 = 3.18 μM). Besides, we also found that the chloro atom at the 7-position on the isatin core was beneficial for the activity through the SARs studies. Among this series, compound 12g showed the best inhibitory activity (IC50 = 4.06 μM) against SH-SY5Y cells, which was comparable to that of 5-FU. Compound 12g arrested cell cycle at G2/M phase, induced apoptosis accompanied with decrease of mitochondrial membrane potential, and inhibited LSD1 potently (IC50 = 3.18 μM). Docking studies showed that compound 12g formed interactions with surrounding amino acid residues and the steroid nucleus occupied the tubular hydrophobic cavity of the active site. Compounds 13–18 represented weak to moderate activity against the tested cancer cell lines. The steroidal dimer 20 and the structurally simplified non-steroidal dimer 21 were found to be devoid of the inhibitory activity. Steroidal hybrids were synthesized and evaluated for their antiproliferative activity. Compound 12g potently inhibited growth of SH-SY5Y cells possibly through the inactivation of LSD1, arrested cell cycle at G2/M phase, induced apoptosis and decreased MMP. Docking simulations were performed to rationalize the potency toward LSD1. [Display omitted] •Steroidal hybrids 12a–x were synthesized and showed varied cytotoxicity against the tested cancer cell lines.•Compounds with terminal isatin scaffold were sensitive to SH-SY5Y cells possibly through LSD1 inactivation.•Compound 12g potently inhibited growth of SH-SY5Y cells (IC50 = 4.06 μM).•Compound 12g arrested cell cycle at G2/M phase, induced apoptosis and decreased MMP.•Docking simulations were performed to show the binding models of compound 12g in the active site of LSD1.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>27105028</pmid><doi>10.1016/j.ejmech.2016.04.024</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0002-5856-4568</orcidid><orcidid>https://orcid.org/0000-0002-7143-9104</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0223-5234
ispartof European journal of medicinal chemistry, 2016-07, Vol.117, p.241-255
issn 0223-5234
1768-3254
language eng
recordid cdi_proquest_miscellaneous_1789498261
source ScienceDirect Freedom Collection
subjects Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Antiproliferative activity
Apoptosis
Catalytic Domain
Cell cycle arrest
Cell Line, Tumor
Docking simulations
Drug Screening Assays, Antitumor
Humans
Inhibitory Concentration 50
Isatin - chemistry
Isatin - pharmacology
LSD1 inactivation
Molecular Docking Simulation
Molecular hybridization
Steroids
Steroids - chemical synthesis
Steroids - pharmacology
Structure-Activity Relationship
title Efficient synthesis of new antiproliferative steroidal hybrids using the molecular hybridization approach
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T01%3A21%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficient%20synthesis%20of%20new%20antiproliferative%20steroidal%20hybrids%20using%20the%20molecular%20hybridization%20approach&rft.jtitle=European%20journal%20of%20medicinal%20chemistry&rft.au=Yu,%20Bin&rft.date=2016-07-19&rft.volume=117&rft.spage=241&rft.epage=255&rft.pages=241-255&rft.issn=0223-5234&rft.eissn=1768-3254&rft_id=info:doi/10.1016/j.ejmech.2016.04.024&rft_dat=%3Cproquest_cross%3E1789498261%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c362t-8314d13087206cbe3b2f84641d5080c5eb397fe7013432c9cd3cfc1bf47e203d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1789498261&rft_id=info:pmid/27105028&rfr_iscdi=true